| 前收市價 | 16.60 |
| 開市 | 16.59 |
| 買盤 | 22.50 |
| 賣出價 | 26.60 |
| 拍板 | 77.50 |
| 到期日 | 2023-03-17 |
| 今日波幅 | 16.59 - 16.60 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 223 |
- Yahoo Finance
Nvidia debuts host of AI technologies and services, capitalizing on ChatGPT hype
Graphics chip giant Nvidia is diving headlong into the hype surrounding generative AI platforms like ChatGPT.
- Benzinga
Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories
Reuters Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move to the private sector from the government. "There are different customers negotiating different prices right now, which is why it's a little bit complicated," the company's president Stephen Hoge said in an interview ahead of a Congressional hearing run by Democratic U.S. Senator Bernie Sanders on Moderna's pricing plans. EU Co
- Financial Times
Google launches Bard chatbot to rival OpenAI’s ChatGPT
Google has launched its Bard chatbot in a bid to rival OpenAI’s popular ChatGPT, as it seeks to make up lost ground in the race to commercialise generative artificial intelligence technology. The tech giant began rolling out the chatbot, its first standalone consumer AI product, on Tuesday. Google said that Bard, which provides answers to text-based questions, will be run separately from its Google Search engine.
